Steen VM - Search Results

1

Non-functional CYP2D6 alleles and risk for neuroleptic-induced movement disorders in schizophrenic patients.

Andreassen OA, MacEwan T, Gulbrandsen AK, McCreadie RG, Steen VM. Andreassen OA, et al. Among authors: steen vm. Psychopharmacology (Berl). 1997 May;131(2):174-9. doi: 10.1007/s002130050281. Psychopharmacology (Berl). 1997. PMID: 9201806

2

Detection of the poor metabolizer-associated CYP2D6(D) gene deletion allele by long-PCR technology.

Steen VM, Andreassen OA, Daly AK, Tefre T, Børresen AL, Idle JR, Gulbrandsen AK. Steen VM, et al. Pharmacogenetics. 1995 Aug;5(4):215-23. doi: 10.1097/00008571-199508000-00005. Pharmacogenetics. 1995. PMID: 8528268

3

Homologous unequal cross-over involving a 2.8 kb direct repeat as a mechanism for the generation of allelic variants of human cytochrome P450 CYP2D6 gene.

Steen VM, Molven A, Aarskog NK, Gulbrandsen AK. Steen VM, et al. Hum Mol Genet. 1995 Dec;4(12):2251-7. doi: 10.1093/hmg/4.12.2251. Hum Mol Genet. 1995. PMID: 8634695

4

Ultrarapid metabolizers of debrisoquine: characterization and PCR-based detection of alleles with duplication of the CYP2D6 gene.

Løvlie R, Daly AK, Molven A, Idle JR, Steen VM. Løvlie R, et al. Among authors: steen vm. FEBS Lett. 1996 Aug 19;392(1):30-4. doi: 10.1016/0014-5793(96)00779-x. FEBS Lett. 1996. PMID: 8769309 Free article.

5

Lack of genetic variation in the coding region of the myo-inositol monophosphatase gene in lithium-treated patients with manic depressive illness.

Steen VM, Gulbrandsen AK, Eiken HG, Berle JO. Steen VM, et al. Pharmacogenetics. 1996 Feb;6(1):113-6. doi: 10.1097/00008571-199602000-00010. Pharmacogenetics. 1996. PMID: 8845858 No abstract available.

6

Characterization and PCR-based detection of two different hybrid CYP2D7P/CYP2D6 alleles associated with the poor metabolizer phenotype.

Daly AK, Fairbrother KS, Andreassen OA, London SJ, Idle JR, Steen VM. Daly AK, et al. Among authors: steen vm. Pharmacogenetics. 1996 Aug;6(4):319-28. doi: 10.1097/00008571-199608000-00005. Pharmacogenetics. 1996. PMID: 8873218

7

Dopamine D3-receptor gene variant and susceptibility to tardive dyskinesia in schizophrenic patients.

Steen VM, Løvlie R, MacEwan T, McCreadie RG. Steen VM, et al. Mol Psychiatry. 1997 Mar;2(2):139-45. doi: 10.1038/sj.mp.4000249. Mol Psychiatry. 1997. PMID: 9106238

8

The polymorphic inositol polyphosphate 1-phosphatase gene as a candidate for pharmacogenetic prediction of lithium-responsive manic-depressive illness.

Steen VM, Løvlie R, Osher Y, Belmaker RH, Berle JO, Gulbrandsen AK. Steen VM, et al. Pharmacogenetics. 1998 Jun;8(3):259-68. Pharmacogenetics. 1998. PMID: 9682271

9

Genomic structure and sequence analysis of a human inositol polyphosphate 1-phosphatase gene (INPP1).

Løvlie R, Gulbrandsen AK, Molven A, Steen VM. Løvlie R, et al. Among authors: steen vm. Pharmacogenetics. 1999 Aug;9(4):517-28. Pharmacogenetics. 1999. PMID: 10780272

10

A human myo-inositol monophosphatase gene (IMPA2) localized in a putative susceptibility region for bipolar disorder on chromosome 18p11.2: genomic structure and polymorphism screening in manic-depressive patients.

Sjøholt G, Gulbrandsen AK, Løvlie R, Berle JO, Molven A, Steen VM. Sjøholt G, et al. Among authors: steen vm. Mol Psychiatry. 2000 Mar;5(2):172-80. doi: 10.1038/sj.mp.4000681. Mol Psychiatry. 2000. PMID: 10822345

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

216 results

Search Page

Filters